Frekil ads, reviews and marketing in August 2026
Frekil is presenting medical image annotation software through a free offer capped at 100 images. Their ad names AI as the product basis but gives little detail about the annotation workflow. You can compete by showing the mechanism, the resulting output, and what users get after the trial limit.
- Researched
- 29 August 2026
- Site
- frekil.com
- Ads read in
- US
- Sources
- 1 of 9 answered
- 1
- ad found
- 0
- reviews found
- 1
- sources read
- Not rated
- review rating
Best opening
Positioning
1 of their 1 fetched ads makes AI the mechanism, so lead with a more specific explanation of how annotation gets done.
Moves worth carrying forward
Campaign
1 of their 1 fetched ads uses a 100-image limit, so state your own trial boundary and the path to continued use.
Creative
1 of their 1 fetched ads shows medical scans but not the annotation action, so make the core interaction visible.
What Frekil is running
Frekil ads, read · 1 of 1 read one by one · 2026-08-29T10:54:18.032Z
Their only fetched ad combines a medical imaging use case with a concrete free-trial limit. The creative gives the offer more prominence than a specific annotation workflow or technical mechanism, leaving room to compete on how annotation works and what happens after 100 images.
- 1
- active ads
- 0%
- video
- 0
- median days running
- 0
- longest run, days
- 1
- creative variants
- not read
- EU reachno detail pass yet
Format
Running for
1 of 1 ad · fetched 2026-08-29 · first run, nothing to compare against
Free access to medical image annotation software! Frekil is offering our AI-powered annotation tool for projects up to
US
Research receiptSources, retention and creditsHide details
What this run read
10 credits spent
Ad copy and review text are quoted from the linked public pages.
This is a public page on kamplyapp.com. It stays up until its owner takes it down.
